Dissemination Strategies and Implementation Outcomes of Adolescent Character Strength Interventions.

February 1, 2023 updated by: Shamiri Institute
The present research study will involve investigating the efficacy of large-scale dissemination models of evidence-based character strength interventions in secondary schools in Kenya. This intervention, derived from a previously tested intervention named Shamiri, or thrive in Kiswahili, uses positive psychology and accessible life skills to build individual resilience and wellness. This will be a one-arm trial with participants recruited from 20 secondary schools in Nairobi, Kiambu and Makueni counties. The investigators estimate a sample size of 3000 youth, working on an intention to treat basis. All interested participants will be admitted to the program, with no exclusion criteria applied. The investigators will report on the efficacy of character strength interventions on wellbeing and mental health outcomes. Further, the investigators will also assess the scalability and acceptability of the program post intervention. Additionally, the investigators will examine moderator effects on the participants, baseline attributes of the participants, and potentially the effects of candidate mediators on intervention effects.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

This is a dissemination study whose objective is to explore the effectiveness, acceptability, and scalability of the Shamiri intervention when implemented in a large-scale naturalistic dissemination study in Kenyan secondary schools. Specifically, this study has two broad goals: 1) to test the effectiveness of Shamiri on mental health and psychosocial outcomes when delivered naturalistically on a large scale through either a centralized and de-centralized (train the trainers) administration, and 2) to examine and measure outcomes of these large-scale dissemination models.

For goal 1, participants will receive Shamiri directly through the Shamiri team or through an implementation partner. The investigators will measure mental health and psychosocial outcomes to determine if these outcomes compare to those reported in prior RCTs of Shamiri. The investigators hypothesize that participants receiving Shamiri will experience similar improvements in mental health and psychosocial outcomes as reported in previous RCTs. The investigators don't have a priori hypothesis on whether the mode through which the participants receive the intervention will affect intervention outcomes.

To achieve goal 2, investigators measure the following implementation related outcomes: intervention fidelity, cost, sustainment, acceptability, penetration, and cost-effectiveness. The investigators hypothesize that the Shamiri intervention will achieve high ratings in all intervention outcomes.

Study Type

Interventional

Enrollment (Actual)

3000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Nairobi, Kenya
        • Shamiri Institute
    • Central Province
      • Kiambu, Central Province, Kenya
        • Shamiri Institute
    • Eastern Province
      • Makueni, Eastern Province, Kenya
        • Africa Mental Health Research and Training Foundation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 21 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Participants must be high school students in one of the selected schools.
  • Participants must be between the ages of 12 to 21.

Exclusion Criteria:

  • There will be no other exclusion criteria.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Shamiri Intervention
The Shamiri intervention group will recieve a brief character strength intervention that will be delivered over the span of 4 weeks. There will be four sessions each lasting one hour each.
The first two sessions focus on the concept of growth mindset, the third session focuses on gratitude, and the fourth and final session focuses on values. In session one, participants are guided through a Growth mindset intervention designed to convey the idea that people and their situations can change for the better. In session two, group leaders introduce a discussion and activities about effective strategies for growth. Then, the group leaders introduce a framework for problem solving. In session three, group leaders emphasize the importance of verbalizing and consciously thinking about Gratitude, as well as its benefits for well-being. In the final session, participants are introduced to the concept of values. Participants discuss stories of culturally pertinent role models, with an emphasis on the values these individuals display, and how their values guided their life decisions and led to success and happiness.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in anxiety symptoms from baseline to 1-month follow up
Time Frame: Baseline, 2-week mid-point, 4-week end-point, and 1-month follow-up
Self-reported anxiety symptoms, measured by the Generalized Anxiety Disorder Screener
Baseline, 2-week mid-point, 4-week end-point, and 1-month follow-up
Change in depression symptoms from baseline to 1-month follow up
Time Frame: Baseline, 2-week mid-point, 4-week end-point, and 1-month follow-up
Self-reported depression symptoms as measured by the Patient Health Questionnaire - 8
Baseline, 2-week mid-point, 4-week end-point, and 1-month follow-up
Change in perceived social support from baseline to 1-month follow up
Time Frame: Baseline, 2-week mid-point, 4-week end-point, and 1-month follow-up
Self-reported sense of social support, measured by the Multidimensional Scale of Perceived Social Support, with a score range of 0-7, with higher scores indicating greater perception of social support
Baseline, 2-week mid-point, 4-week end-point, and 1-month follow-up
Change in self-reported well-being from baseline to 1-month follow up
Time Frame: Baseline, 2-week mid-point, 4-week end-point, and 1-month follow-up
Self-reported wellbeing, as measured by the Engagement, Perseverance, Optimism, Connectedness and Happiness Measure of Adolescent Well-Being, with a score range of 1-5, higher scores meaning better well-being
Baseline, 2-week mid-point, 4-week end-point, and 1-month follow-up
Change in academic performance from baseline to 1-month follow up
Time Frame: Baseline (academic term pre-intervention) and up to 1-month post intervention
Academic performance, as measured by the average grade achieved from the school term before the intervention, the school term during which the intervention takes place, and the last term for which academic grades are available.
Baseline (academic term pre-intervention) and up to 1-month post intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in self-reported secondary control from baseline to 1-month follow up
Time Frame: Baseline, 2-week mid-point, 4-week end-point, and 1-month follow-up
Self-reported participant sense of secondary control, or the ability to adjust oneself to hardships in such a way as to control their subjective emotional impact, measured by the 6-item short form of the Secondary Control Scale for Children (score range of 0-18, higher scores indicating greater perceived secondary control)
Baseline, 2-week mid-point, 4-week end-point, and 1-month follow-up
Change in sense of meaning and purpose in life from baseline to 1-month follow up
Time Frame: Baseline, 2-week mid-point, 4-week end-point, and 1-month follow-up
Self-reported sense of purpose and meaning in life, as measured by the Purpose in Life Scale-12, with a score range of 20-140, higher scores indicating greater perceived meaning in life
Baseline, 2-week mid-point, 4-week end-point, and 1-month follow-up
Change in gratitude from baseline to 1-month follow up
Time Frame: Baseline, 2-week mid-point, 4-week end-point, and 1-month follow-up
Self-reported gratitude, measured by a 6-item version of the Gratitude Questionnaire, with a score range of 6-48, with higher scores indicating higher gratitude
Baseline, 2-week mid-point, 4-week end-point, and 1-month follow-up
Change in perceived control from baseline to 1-month follow up
Time Frame: Baseline, 2-week mid-point, 4-week end-point, and 1-month follow-up
Self-reported sense of control over oneself and one's life, measured by the Perceived Control Scale for Children, with a score range of 0-24, with a higher score indicating higher perception of control over one's life
Baseline, 2-week mid-point, 4-week end-point, and 1-month follow-up
Change in mental well-being from baseline to 1-month follow up
Time Frame: Baseline, 2-week mid-point, 4-week end-point, and 1-month follow-up
Self-reported mental well-being of participants measured by the Short Warwick-Edinburgh Mental Well-being Scale (SWEMWBS), with a score range of 7-35, higher scores indicating higher positive mental well-being
Baseline, 2-week mid-point, 4-week end-point, and 1-month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 16, 2022

Primary Completion (Actual)

June 30, 2022

Study Completion (Actual)

October 31, 2022

Study Registration Dates

First Submitted

April 25, 2022

First Submitted That Met QC Criteria

May 3, 2022

First Posted (Actual)

May 9, 2022

Study Record Updates

Last Update Posted (Actual)

February 2, 2023

Last Update Submitted That Met QC Criteria

February 1, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Templeton 2 Phase 2

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The investigators intend to share fully de-identified data through publications and upon request.

IPD Sharing Time Frame

T.B.D.

IPD Sharing Access Criteria

T.B.D.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mental Health Disorder

Clinical Trials on Shamiri Intervention

Subscribe